M
MAZE//CIK 0001842295
Maze Therapeutics, Inc.
Market Data
$46.01+$4.62 (+11.16%)
MAZE · Last trade
Prev Close
$41.39
Range (30d)
$39.81 – $48.37
Recent Filings
- 8-K152.5 KBMaze Therapeutics, Inc.Feb 4, 4:45 PM ET·0001193125-26-037747
- 10-Q9.6 MBMaze Therapeutics, Inc.Nov 6, 4:27 PM ET·0001193125-25-269689
- 8-K381.5 KBMaze Therapeutics, Inc.Nov 6, 4:21 PM ET·0001193125-25-269624
- S-1629.2 KBMaze Therapeutics, Inc.Oct 17, 4:15 PM ET·0001193125-25-242526
- 8-K143.7 KBMaze Therapeutics, Inc.Oct 6, 7:30 AM ET·0001193125-25-230926
- 8-K688.1 KBMaze Therapeutics, Inc.Sep 11, 7:48 AM ET·0001193125-25-200760
- 8-K145.8 KBMaze Therapeutics, Inc.Sep 2, 7:00 AM ET·0001193125-25-193353
- 10-Q8.0 MBMaze Therapeutics, Inc.Aug 12, 4:08 PM ET·0000950170-25-107306
- 8-K379.6 KBMaze Therapeutics, Inc.Aug 12, 4:06 PM ET·0000950170-25-107299
- 10-Q6.4 MBMaze Therapeutics, Inc.May 14, 4:06 PM ET·0000950170-25-071375
Insiders
10- Andrews Nancy CDirector
- ARCH Venture Fund X, L.P.10% Owner
- ARCH Venture Partners X, LLC10% Owner
- Bachrodt AmySVP, Finance
- Bernstein HaroldPresident, R&D & CMO
- Brush JamesDirector
- Burow Kristina10% Owner
- Coloma Jason VDirector, Chief Executive Officer
- Colowick AlanDirector
- Courtney PhillipsGC and Corp. Secretary
Tickers
Addresses
business
171 OYSTER POINT BOULEVARD, SUITE 300
SOUTH SAN FRANCISCO, CA, 94080
mailing
171 OYSTER POINT BOULEVARD, SUITE 300
SOUTH SAN FRANCISCO, CA, 94080